Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Gururangan, S; Cokgor, I; Rich, JN; Edwards, S; Affronti, ML; Quinn, JA; Herndon, JE; Provenzale, JM; McLendon, RE; Tourt-Uhlig, S; Sampson, JH; Stafford-Fox, V; Zaknoen, S; Early, M; Friedman, AH; Friedman, HS
   Phase I study of Gliadel (TM) wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas
   NEURO-ONCOLOGY
   
   S. Gururangan et al., "Phase I study of Gliadel (TM) wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas", NEURO-ONCOL, 3(4), 2001, pp. 246-250
2. Brada, M; Hoang-Xuan, K; Rampling, R; Dietrich, PY; Dirix, LY; Macdonald, D; Heimans, JJ; Zonnenberg, BA; Bravo-Marques, JM; Henriksson, R; Stupp, R; Yue, N; Bruner, J; Dugan, M; Rao, S; Zaknoen, S
   Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
   ANNALS OF ONCOLOGY
   
   M. Brada et al., "Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse", ANN ONCOL, 12(2), 2001, pp. 259-266
3. Yung, WKA; Albright, RE; Olson, J; Fredericks, R; Fink, K; Prados, MD; Brada, M; Spence, A; Hohl, RJ; Shapiro, W; Glantz, M; Greenberg, H; Selker, RG; Vick, NA; Rampling, R; Friedman, H; Phillips, P; Bruner, J; Yue, N; Osoba, D; Zaknoen, S; Levin, VA
   A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
   BRITISH JOURNAL OF CANCER
   
   W.K.A. Yung et al., "A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse", BR J CANC, 83(5), 2000, pp. 588-593
4. Yung, WKA; Prados, MD; Yaya-Tur, R; Rosenfeld, SS; Brada, M; Friedman, HS; Albright, R; Olson, J; Chang, SM; O'Neill, AM; Friedman, AH; Bruner, J; Yue, N; Dugan, M; Zaknoen, S; Levin, VA
   Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse
   JOURNAL OF CLINICAL ONCOLOGY
   
   W.K.A. Yung et al., "Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse", J CL ONCOL, 17(9), 1999, pp. 2762-2771
5. WALDMANN TA; WHITE JD; CARRASQUILLO JA; REYNOLDS JC; PAIK CH; GANSOW OA; BRECHBIEL MW; JAFFE ES; FLEISHER TA; GOLDMAN CK; TOP LE; BAMFORD R; ZAKNOEN S; ROESSLER E; KASTENSPORTES C; ENGLAND R; LITOU H; JOHNSON JA; JACKSONWHITE T; MANNS A; HANCHARD B; JUNGHANS RP; NELSON DL
   RADIOIMMUNOTHERAPY OF INTERLEUKIN-2R-ALPHA-EXPRESSING ADULT T-CELL LEUKEMIA WITH YTTRIUM-90-LABELED ANTI-TAC
   Blood
   
   T.A. Waldmann et al., "RADIOIMMUNOTHERAPY OF INTERLEUKIN-2R-ALPHA-EXPRESSING ADULT T-CELL LEUKEMIA WITH YTTRIUM-90-LABELED ANTI-TAC", Blood, 86(11), 1995, pp. 4063-4075
6. GELLER RB; TARANTOLO S; POWELL BL; KALAYCIOGLU M; ZAKNOEN S; KLEIN L; GARRISON L
   PHASE-II STUDY OF PIXY321 IN ELDERLY PATIENTS (PTS) WITH NEWLY-DIAGNOSED ACUTE MYELOCYTIC-LEUKEMIA (AML)
   Blood
   
   R.B. Geller et al., "PHASE-II STUDY OF PIXY321 IN ELDERLY PATIENTS (PTS) WITH NEWLY-DIAGNOSED ACUTE MYELOCYTIC-LEUKEMIA (AML)", Blood, 86(10), 1995, pp. 3026-3026
7. KASTENSPORTES C; ZAKNOEN S; STEIS RG; CHAN WC; WINTON EF; WALDMANN TA
   T-CELL RECEPTOR GENE REARRANGEMENT IN T-CELL LARGE GRANULAR LEUKOCYTELEUKEMIA - PREFERENTIAL-V-ALPHA BUT DIVERSE-J-ALPHA USAGE IN ONE OF 5PATIENTS
   Blood
   
   C. Kastensportes et al., "T-CELL RECEPTOR GENE REARRANGEMENT IN T-CELL LARGE GRANULAR LEUKOCYTELEUKEMIA - PREFERENTIAL-V-ALPHA BUT DIVERSE-J-ALPHA USAGE IN ONE OF 5PATIENTS", Blood, 83(3), 1994, pp. 767-775
8. WALDMANN TA; GOLDMAN CK; TOP L; GANSOW O; KASTENSPORTES C; ROESSLER E; ZAKNOEN S; WHITE J; HORAK I; CARRASQUILLO JA; REYNOLDS JC; NELSON DL
   THE TREATMENT OF HTLV-I-ASSOCIATED ADULT T-CELL LEUKEMIA (ATL) WITH GENETICALLY ENGINEERED MONOCLONAL-ANTIBODIES ARMED WITH RADIONUCLIDES
   Journal of acquired immune deficiency syndromes
   
   T.A. Waldmann et al., "THE TREATMENT OF HTLV-I-ASSOCIATED ADULT T-CELL LEUKEMIA (ATL) WITH GENETICALLY ENGINEERED MONOCLONAL-ANTIBODIES ARMED WITH RADIONUCLIDES", Journal of acquired immune deficiency syndromes, 6(6), 1993, pp. 671-671
9. WALDMANN TA; WHITE JD; GOLDMAN CK; TOP L; GRANT A; BAMFORD R; ROESSLER E; HORAK ID; ZAKNOEN S; KASTENSPORTES C; ENGLAND R; HORAK E; MISHRA B; DIPRE M; HALE P; FLEISHER TA; JUNGHANS RP; JAFFE ES; NELSON DL
   THE INTERLEUKIN-2 RECEPTOR - A TARGET FOR MONOCLONAL-ANTIBODY TREATMENT OF HUMAN T-CELL LYMPHOTROPHIC VIRUS-I-INDUCED ADULT T-CELL LEUKEMIA
   Blood
   
   T.A. Waldmann et al., "THE INTERLEUKIN-2 RECEPTOR - A TARGET FOR MONOCLONAL-ANTIBODY TREATMENT OF HUMAN T-CELL LYMPHOTROPHIC VIRUS-I-INDUCED ADULT T-CELL LEUKEMIA", Blood, 82(6), 1993, pp. 1701-1712